🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Non-small Cell Lung Cancer Stage III

Pulmonary Rehabilitation in Advanced Lung Cancer Survivors NCT07104630Phase 21 site📍 Cleveland Case Comprehensive Cancer Center · Tests: Pulmonary Rehabilitation (PR), No intervention: Usual care Pathological Response After Neoadjuvant Treatment on NSCLC NCT05167487n/a17 sites📍 A Coruña📍 Alicante📍 Badalona Fundación GECP · Tests: Cisplatin, Carboplatin Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy NCT05398094Phase 220 sites📍 Alicante📍 Badalona📍 Barcelona Fundación GECP · Tests: Sotorasib A Prospective Phase II Clinical Study of Immunotherapy Combined With Chemotherapy for Stage III Unresectable Non-small Cell Lung Cancer NCT07082179Phase 21 site📍 Nanjing Jiangsu Cancer Institute & Hospital · Tests: Iparomlimab and Tuvonralimab combined with paclitaxel polymer micelles and Platinum (cisplatin/carboplatin) JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation NCT06416410Phase 337 sites📍 Hefei📍 Beijing📍 Beijing Allist Pharmaceuticals, Inc. · Tests: JAB-21822, Tislelizumab, JAB-3312, Pemetrexed, Carboplatin Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) NCT07154706Phase 333 sites📍 Los Angeles📍 Orange📍 Washington D.C. Nuvation Bio Inc. · Tests: Taletrectinib, Placebo Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance NCT05692635Phase 21 site📍 Winston-Salem Wake Forest University Health Sciences · Tests: MRI of the Brain, Blood draws, Quality of Life Questionnaires, Gadolinium RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC NCT07541521n/a10 sites📍 Fuzhou📍 Guangzhou📍 Shenzhen Shanghai Chest Hospital · Tests: Robot-assisted thoracoscopic surgery (RATS) sleeve lobectomy Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients NCT06634199n/a22 sites📍 Ferrol📍 Alicante📍 Badalona Fundación GECP · Tests: Durvalumab Concurrent Neoadjuvant Chemoradiotherapy Plus Durvalumab (MEDI4736) in Resectable Stage III NSCLC NCT03694236Phase 1, Phase 21 site📍 Seoul Yonsei University · Tests: durvalumab Neoadjuvant IBI308, Bevacizumab, Plus Pemetrexed and Carboplatin Followed by Surgery in Unresectable Stage III NSCLC NCT03872661Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: IBI308, Bevacizumab, Pemetrexed, Carboplatin, Thoracic surgery A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung Cancer NCT05654454Phase 328 sites📍 Arkhangelsk📍 Ivanovo📍 Kaluga Mabscale, LLC · Tests: Bevacizumab, Paclitaxel, Carboplatin Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation NCT07012031Phase 1, Phase 29 sites📍 Sacramento📍 Tampa📍 Tampa National Cancer Institute (NCI) · Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Echocardiography Test, Magnetic Resonance Imaging A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC) NCT04302025Phase 238 sites📍 Duarte📍 Irvine📍 Los Angeles Genentech, Inc. · Tests: Alectinib, Entrectinib, Vemurafenib, Cobimetinib, Pralsetinib JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer NCT02468024Phase 350 sites📍 La Jolla📍 Aurora📍 Colorado Springs University of Texas Southwestern Medical Center · Tests: Lung Surgery, Radiation therapy A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer NCT06868277Phase 3304 sites📍 La Mesa📍 Los Alamitos📍 Newark AstraZeneca · Tests: Rilvegostomig, Pembrolizumab Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients NCT06114108NA7 sites📍 Aarau📍 Bellinzona📍 Chur Swiss Cancer Institute · Tests: Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy), Surgery, Radiotherapy The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients NCT06082492NA27 sites📍 Hilversum📍 Amsterdam📍 Amsterdam Radboud University Medical Center · Tests: 18F FDG PET/CT, CT scan Nitroglycerin Plus Radiotherapy Versus Conventional Radiotherapy in Patients With Lung Cancer. NCT06238882NA1 site📍 Mexico City Instituto Nacional de Cancerologia de Mexico · Tests: Nitroglycerin Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. NCT06167460n/a1 site📍 Ho Chi Minh City Gene Solutions Effect of Infusion Timing on Pathologic Response to Neoadjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer NCT07251582Phase 32 sites📍 Changsha📍 Changsha Hunan Province Tumor Hospital · Tests: Time of Day-based Assignment for Infusion of Immune Checkpoint Inhibitor (e.g., toripalimab, or pembrolizumab) + platin… Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer NCT07250477Phase 24 sites📍 Chico📍 Marysville📍 Sacramento University of California, Davis · Tests: Systemic (ICI)-based therapy informed by the PROphet CB assay and the CARG-TT assessment., Standard of Care Neoadjuvant Treatment With Atezolizumab and Atezolizumab as Maintenance for the Treatment of Stage III Non Small-Cell Lung Cancer (NSCLC) NCT07153445Phase 221 sites📍 Alicante📍 Badalona📍 Barcelona Fundación GECP · Tests: Atezolizumab, Paclitaxel, Carboplatin A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC NCT06627647Phase 3301 sites📍 Mobile📍 Chandler📍 Phoenix AstraZeneca · Tests: Rilvegostomig, Pembrolizumab, Carboplatin, Cisplatin, Pemetrexed Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC NCT06810609Phase 25 sites📍 Freiburg im Breisgau📍 Stuttgart📍 Giessen University Hospital, Bonn · Tests: surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance… Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma NCT07314216Phase 21 site📍 Changsha Hunan Cancer Hospital · Tests: Firmonertinib, Definitive Thoracic Radiotherapy Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) NCT07680790Phase 3204 sites📍 Beverly Hills📍 Fullerton📍 La Jolla Bristol-Myers Squibb · Tests: Iza-bren, Osimertinib, Pemetrexed, Carboplatin, Cisplatin Cardiovascular Injury and Cardiac Fitness in Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Model Based Personalized Chemoradiation NCT05010109NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: 6 Minute Walk Functional Test, Biospecimen Collection, Computed Tomography, Echocardiography, Exercise Cardiac Stress T… Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH) NCT06437977Phase 31 site📍 Shanghai Shanghai Chest Hospital · Tests: SBRT, Toripalimab Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO) NCT05382728Phase 32 sites📍 Changsha📍 Shanghai TYK Medicines, Inc · Tests: TY-9591, placebo Osimertinib, Osimertinib, placebo TY-9591
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy